Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2 (CONFOCAL-2) Interventional Pilot Study

NCT07296029 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT07296029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07296029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness-2 (CONFOCAL-2) Interventional Pilot Study
Lead sponsor
Queen's University
Phase
Phase 1/2
Overall status
Completed
Start date
July 29, 2022
Completion date
February 8, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, delirium, respiratory failure, shock